Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 48 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
471 18.0 months Metastatic breast cancer 4 Chemotherapy
Mayo Clinic and Mayo Foundation United States 8/2002
Treatment Details: Patients: This Phase II study involved 33 patients with metastatic breast cancer. Treatment: Treatment consisted of three drugs – docetaxel (taxotere), doxorubicin (adriamycin), and cyc
 
472 18.0 months Hormone-refractory prostate cancer 4 Chemotherapy
University of Michigan United States 12/2005
Treatment Details: Patients: This study involved 42 men with chemotherapy-naive metastatic hormone-resistant prostate cancer. The median age was 73 years. None of the patients had received chemotherapy prior
 
473 18.0 months Peritoneal carcinomatosis from colon adenocarcinoma 4 Biologic therapy
Chemotherapy
Surgery
University of Padova Italy 6/2003
Treatment Details: Patients: This Phase II study involved 46 patients treated for peritoneal carcinomatosis from colon adenocarcinoma. Treatment: Thirty-four patients were treated with complete cytoreducti
 
474 18.0 months Hormone refractory prostate cancer 4 Chemotherapy
Hospital Germans Trias i Pujol Spain 3/2005
Treatment Details: Patients: This Phase II study enrolled 30 men with hormone refractory metastatic prostate cancer. The median age was 69. Metastatic sites included bone, lymph nodes, lung, and liver. Eigh
 
475 18.0 months Hormone-refractory prostate cancer 3 Biologic therapy
University of Athens School of Medicine Greece 1/2004
Treatment Details: Patients: This Phase II study involved 38 patients with hormone refractory prostate cancer. Patients were divided into two groups: Group 1 and Group 2. The average age of patients in Group
 
476 18.0 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Hospital La Paz/Autónoma University School of Medicine Spain 4/2010
Treatment Details: Patients: This study involved 59 metastatic colorectal cancer patients with a median age of 75 years, 58% of whom were male. Treatment: Patients were treated with the chemotherapy agent
 
477 18.0 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
University of Pittsburgh United States 11/2011
Treatment Details: Patients: This phase II study involved women with previously treated but recurrent or metastatic breast cancer who were divided into two separate treatment groups. Group A included 225 pat
 
478 18.0 months Malignant pleural mesothelioma 5 Radiation
Mount Sinai Medical Center United States 7/2012
Treatment Details: Patients: This study involved 36 malignant pleural mesothelioma patients. The median patient age was 67 years and 81% were male. Treatment: Patients were treated with intensity-modulat
 
479 18.0 months Advanced urothelial cancer 4 Chemotherapy
Athens University Medical School Greece 4/2013
Treatment Details: Patients: This phase 3 study involved advanced urothelial cancer patients who were divided into two separate treatment groups. Group A consisted of 63 patients with a median age of 66 year
 
480 18.0 months Advanced cutaneous T-cell lymphoma 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 11/2013
Treatment Details: Patients: This phase 2 study involved 37 advanced cutaneous T-cell lymphoma patients. The median patient age was 56 years and 54% were male. Treatment: Patients were treated with the c
 
Page 48 of 187  | Previous Page  | Next Page